CLINICAL_TRIALS
research
· 2025-04-02
Clinical Trial Update: Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension
Summary
Clinical trial investigating hyperpolarized 129Xe MRI biomarkers to evaluate pulmonary arterial hypertension; status is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Kansas Medical Center | Conditions: Pulmonary Arterial Hypertension | Status: ACTIVE_NOT_RECRUITING